Sands Capital Management
BIIB icon

Sands Capital Management’s Biogen BIIB Stock Holding History

Sands Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,138,777
Closed -$363M – 68
2017
Q4 		$363M Sell
1,138,777
-68,395
-6% -$21.9M 1.1% 29
2017
Q3 		$378M Sell
1,207,172
-70,991
-6% -$21M 1.13% 31
2017
Q2 		$347M Sell
1,278,163
-1,197,774
-48% -$317M 1.04% 29
2017
Q1 		$677M Sell
2,475,937
-102,972
-4% -$29.1M 2.13% 17
2016
Q4 		$731M Sell
2,578,909
-210,357
-8% -$62.4M 2.55% 16
2016
Q3 		$873M Sell
2,789,266
-180,964
-6% -$53.6M 2.57% 16
2016
Q2 		$718M Sell
2,970,230
-170,879
-5% -$45M 2.22% 19
2016
Q1 		$818M Sell
3,141,109
-226,422
-7% -$59.8M 2.42% 17
2015
Q4 		$1.03B Sell
3,367,531
-753,869
-18% -$217M 2.66% 16
2015
Q3 		$1.2B Sell
4,121,400
-611,545
-13% -$202M 3.36% 10
2015
Q2 		$1.91B Sell
4,732,945
-276,670
-6% -$111M 4.7% 5
2015
Q1 		$2.12B Buy
5,009,615
+35,284
+0.7% +$13.9M 5.03% 6
2014
Q4 		$1.69B Buy
4,974,331
+22,235
+0.4% +$7.19M 4.02% 8
2014
Q3 		$1.64B Buy
4,952,096
+60,633
+1% +$20M 4.07% 7
2014
Q2 		$1.54B Buy
4,891,463
+18,446
+0.4% +$5.55M 3.89% 9
2014
Q1 		$1.49B Buy
4,873,017
+118,857
+3% +$37.7M 3.88% 9
2013
Q4 		$1.33B Buy
4,754,160
+118,919
+3% +$30.8M 3.47% 10
2013
Q3 		$1.12B Buy
4,635,241
+69,320
+2% +$15.5M 3.11% 13
2013
Q2 		$983M Buy
+4,565,921
New +$976M 3.31% 11

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sands Capital Management's BIIB Position: Q1 2018 in Review

Sands Capital Management sold out of Biogen (BIIB) in Q1 2018, closing a stake of 1,138,777 shares — an estimated $363M sold.

Sands Capital Management first reported a position in BIIB in Q2 2013 and held it in 19 quarters. The position peaked at $2.12B in Q1 2015. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Sands Capital Management reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Sands Capital Management sold 1,138,777 Biogen shares in Q1 2018, an estimated $363M.
  • Sands Capital Management first reported a position in Biogen in Q2 2013 and held it in 19 quarters.
  • Sands Capital Management's Biogen position peaked at $2.12B in Q1 2015.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Sands Capital Management's 13F filing for Q1 2018, filed 15 May 2018.